Filter
438
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
109
Language
Document type
No document type
268
Guidelines
63
Studies & Reports
56
Manuals
27
Strategic & Response Plan
13
Situation Updates
4
Training Material
3
Fact sheets
3
Infographics
1
Countries / Regions
India
21
Uganda
14
Kenya
14
Liberia
13
South Africa
12
Global
11
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Sierra Leone
8
Malawi
8
Western and Central Europe
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Namibia
6
Asia
6
Ghana
5
Cambodia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Eastern Europe and Central Asia
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Africa
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
41
Pharmacy & Technologies
19
Public Health
13
Key Resources
13
Women & Child Health
12
Capacity Building
8
Toolboxes
HIV
55
Mental Health
34
TB
32
Pharmacy
27
COVID-19
23
NTDs
15
Malaria
15
AMR
14
Ebola & Marburg
10
Rapid Response
9
Caregiver
6
Health Financing Toolbox
5
Conflict
4
Planetary Health
4
NCDs
4
2.0 Rapid Response
4
Natural Hazards
3
Global Health Education
3
Refugee
2
Specific Hazards
2
Disability
1
Zika
1
Social Ethics
1
WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.
Key populations brief.
Краткое руководство
Training Manual
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati
...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused in name, it offers integration-oriented assessment,
...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
Key populations brief.
Informe sobre poblaciones clave.
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
In 2014, GHS/NACP, with support from UNICEF and other partners, conducted a situation analysis on paediatric HIV care and treatment in Ghana. The purpose of this analysis was to identify the gaps within the current delivery of paediatric HIV care and support system and develop a road map for effecti
...
